Serum cholesterol response to dietary cholesterol.
Explore the source record for details and available documents.
Biomedical subjects
Publications and source records attributed to A Keys.
Explore the source record for details and available documents.
In 15 cohorts of the Seven Countries Study, comprising 11,579 men aged 40-59 years and "healthy" at entry, 2,288 died in 15 years. Death rates differed among cohorts. Differences in mean age, blood pressure, serum cholesterol, and smoking habits "explained" 46% of variance in death rate from all causes, 80% from coronary heart disease, 35% from cancer, and 45% from stroke. Death rate differences were unrelated to cohort differences in mean relative body weight, fatness, and physical activity. The cohorts differed in average diets. Death rates were related positively to average percentage of dietary energy from saturated fatty acids, negatively to dietary energy percentage from monounsaturated fatty acids, and were unrelated to dietary energy percentage from polyunsaturated fatty acids, proteins, carbohydrates, and alcohol. All death rates were negatively related to the ratio of monounsaturated to saturated fatty acids. Inclusion of that ratio with age, blood pressure, serum cholesterol, and smoking habits as independent variables accounted for 85% of variance in rates of deaths from all causes, 96% coronary heart disease, 55% cancer, and 66% stroke. Oleic acid accounted for almost all differences in monounsaturates among cohorts. All-cause and coronary heart disease death rates were low in cohorts with olive oil as the main fat. Causal relationships are not claimed but consideration of characteristics of populations as well as of individuals within populations is urged in evaluating risks.
Explore the source record for details and available documents.
In the Seven Countries Study, carried out in Finland, Greece, Italy, Japan, The Netherlands, the United States, and Yugoslavia, among 11,325 "healthy" men aged 40-59 years in 15 years, there were 594 cancer deaths. Among 477 cancer deaths five years after cholesterol measurement, there was a significant excess of lung cancer deaths in the bottom 20% of the cholesterol distributions in the populations. Age, blood pressure, smoking habits, occupation, and relative body weight did not help explain this. A U-shaped relationship between cancer and cholesterol was not seen in any population. Trend analysis with various cutting points indicated increasing risk of lung cancer death at cholesterol levels under 170 mg/dl. The 45 men dead from cancer in the first two years had lower cholesterol levels than their compatriots who died from cancer later but they did not differ in relative weight or fatness. In contrast to relationships for individuals within populations, the highest cancer death rates were in northern Europe, where the general level of cholesterol was also highest. Other characteristics of the populations--age, relative weight, smoking habits, blood pressure, physical activity, and vitamin A and ascorbic acid in the diet--did not help in the attempt to understand the regional differences in cancer mortality. There is no evidence that any of the observed cancer-serum cholesterol relationships among or within the populations involve an effect of serum cholesterol concentration on oncogenesis or cancer mortality but the possibility of such an effect cannot be denied.
Among 11,579 men ages 40-59 without evidence of cardiovascular disease, 2,289 died in 15 years, 618 from coronary heart disease. The 15 cohorts in seven countries (four regions) differed in all-causes death rate, mainly reflecting great differences in coronary mortality. Among characteristics of entry, only mean blood pressure helped to explain cohort differences in all-causes death rate. Three-quarters of the variance in coronary death rate was accounted for by differences in mean serum cholesterol and blood pressure of the cohorts. The mortality risk for individuals was examined in each of the regions. For coronary death, age, serum cholesterol, blood pressure, and smoking were highly significant in all regions except Japan, where coronary deaths were too few for evaluation. Relative weight was not significant anywhere. Physical activity was significant only in southern Europe, where differences are associated with socioeconomic status. For all-causes death, age and blood pressure were highly significant risk factors in all regions as was smoking habit, except in Japan. Relative body weight tended to be a negative risk factor everywhere, significantly so in southern Europe. Expectations for coronary death from the experience in the United States and northern Europe greatly exceeded observed deaths in southern Europe for men of their age, serum cholesterol, blood pressure, smoking habits, physical activity, and relative weight. The reverse, prediction of coronary deaths in America and in northern Europe from the southern European experience, greatly underestimated the deaths observed. Similar cross-predictions between the United States and northern Europe were good for all-causes deaths, excellent for coronary deaths. Analysis of time trends in relationships of mortality to entry characteristics showed continued importance of age, blood pressure, and smoking and a tendency for the importance of cholesterol to fall in the last 5 years of follow-up.
Explore the source record for details and available documents.
Serum cholesterol change, delta Chol mg/dl, from change only in dietary cholesterol, mg/1,000 kcal, x, was analyzed with data from 39 controlled experiments on 64 adults with the model delta Chol = b(x2k-x1k). Values of b were found by iteration for exponents k = 0.3 to k = i.0 yielding eight regression equations to check predicted against observed. The smallest root mean square deviation regression was 7 mg/dl given by delta Chol = 1.5(x2(1/2)-x1(1/2] which predicted an average serum cholesterol change of 18.7 versus 19.9 observed. The relationship pertains to calorie balance on a wide range of nutritionally acceptable diets. A prediction equation proposed from experiments in Massachusetts that took k = 1.0 overpredicted the effect of dietary cholesterol in these experiments by 300%.
Forced vital capacity (VC) and forced expiratory volume at 0.75 s (FEV) were measured in 592 Cretan island men aged 25 to 74 in 1960, 1965, and 1970. Vital capacity and FEV were directly correlated with height, but percentage changes were unrelated to height. A prominent accelerating decrease with age was also observed, the longitudinal decrement becoming more marked with advancing age. Chronic obstructive lung disease at entry significantly accelerated the loss of lung capacity, more so for emphysema than for chronic bronchitis. Among heavier men, body weight gains intensified the age-dependent loss of vital capacity and FEV. Borderline statistically significant differences in FEV decreases (adjusted for age, height and entry FEV) were seen between cigarette smoking groups. Heavy smokers had more diagnoses of chronic bronchitis and emphysema. Modifiable factors in minimizing the decrease of lung capacity with age include obesity, obstructive lung disease, and smoking, the last through development of chronic obstructive lung disease.
Examinations of 'healthy' men in Helsinki and in rural west and east Finland in 1956 included estimation of total cholesterol and that in the HDL and beta fractions separated by electrophoresis. Vital status to the end of 1980 has been ascertained for all but eight of the 526 men aged 35-61 and for all but two of 261 men aged 30-34 at entry. Among the men aged 35-61, in 24 years 155 died, 63 from coronary heart disease; among the men aged 30-34, 36 died, 16 from coronary heart disease. All causes and coronary death rates were highest in east Finland where HDL cholesterol was also highest. Coronary death rates were not related to HDL cholesterol in east or west Finland but 16 men dead from coronary heart disease in Helsinki tended to have low HDL values. Consideration of five other entry characteristics did not change the picture with regard to HDL-mortality relationships. Solution of the multiple logistic equation using all those variables found the probability of 24-year coronary death was not significantly related to HDL but was significantly related, positively, to the non-HDL cholesterol concentration. HDL and total cholesterol mean values for men of the same age in the same area of Finland, with lipoprotein separation by the new recommended methods, agree closely with the means recorded in 1956. These 24-year findings are not necessarily in conflict with reports in the literature on an inverse relationship between coronary heart disease incidence and HDL cholesterol based on much shorter periods of follow-up and few data on mortality.
Explore the source record for details and available documents.
The currently popular view that a high concentration of high density (alpha) lipoprotein (HDL) in the blood plasma protects against coronary heart disease is based on publications which compare persons with and without the disease and persons who develop the disease within a few years after the analysis of the plasma. Very little attention has been paid to mortality and the follow-up period has been short. A recent report on civil servants in Israel claims an important inverse relationship between HDL cholesterol and mortality. The HDL values reported, however, differ greatly from all other published values, and the period of follow-up was less than 5 years. In addition, the statistics showing the protective effect of HDL cholesterol depend largely on the ratio of HDL to total cholesterol which really shows that, as is well known, the total cholesterol concentration is a positive risk factor for coronary heart disease. A 25-year follow-up of Minnesota business and professional men aged 50 to 60 at entry who were examined annually through 1978 produced no evidence that either total or coronary mortality was significantly related to the concentration of plasma HDL. The material covers 135 deaths, including 55 from coronary heart disease. The data actually suggest that the probability of death from neoplastic disease is directly related to the concentration of HDL cholesterol in the plasma or at least that there may be a trade-off between coronary heart disease and cancer death in respect to HDL cholesterol. The view that the higher the level of HDL cholesterol the better needs reexamination with attention to mortality during long follow-up.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Data from the Seven Countries Study are analysed to examine the relationship between the observed incidence of Coronary Heart Disease in the second 5-year period of follow-up and the major entry risk factors and their changes over the first 5 years. The analysis, using the Multiple Logistic Function model, shows that changes in systolic blood pressure and smoking habits are significant factors associated with incidence, while changes in cholesterol and body mass index do not play this role. This conclusion applies to the population as a whole. A more detailed analysis, stratifying the population by estimated risk at entry and changes of risk over 5 years, shows that incidence is related to changes of risk in low and medium entry risk groups. Moreover, a univariate analysis of data limited to systolic blood pressure and cholesterol indicates that changes in blood pressure are related to incidence in the group with highest entry level of blood pressure, while changes in cholesterol are irrelevant to subsequent incidence.
Explore the source record for details and available documents.
The Minnesota Prospective Study on coronary heart disease (CHD) in 284 business and professional men began in 1947. In 1953 and 1955 measurements were made of serum alpha-lipoprotein (HDL) cholesterol on the men. The mean was 45 . 2 mg/dl, the same as reported for HDL cholesterol in men of that age at Framingham. As with HDL at Framingham and elsewhere, alpha cholesterol was not correlated with age, blood-pressure, total cholesterol, or smoking habit, but was negatively correlated (r=-0.37) with relative body-weight. In the next 25 years 133 men died, 55 from CHD. Mean alpha cholesterol of those who died from CHD was lower than that of men dying from other causes but was not significantly different from the mean of the 120 men alive in 1978. Of all groups classified by 25-year outcome, the 32 men who died from neoplasms had the highest mean alpha cholesterol at entry, differing significantly from survivors. Multivariate analysis did not change the relationships. Consideration of CHD only and follow-up of only a few years may greatly distort evaluation of the overall long-term significance of HDL cholesterol concentration in the plasma.
Explore the source record for details and available documents.
Explore the source record for details and available documents.